Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN98241100
ISRCTN98241100
Completed
未知

Randomised trial of interstitial brachytherapy as a component of radical radiotherapy for localised prostatic carcinoma

HS R&D Regional Programme Register - Department of Health (UK)0 sites218 target enrollmentJanuary 23, 2004
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsProstate cancerCancerProstate

Overview

Phase
未知
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
HS R&D Regional Programme Register - Department of Health (UK)
Enrollment
218
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22341794 results 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31059955 results (added 08/05/2019)

Registry
who.int
Start Date
January 23, 2004
End Date
July 7, 2004
Last Updated
4 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
HS R&D Regional Programme Register - Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

  • •Patients with prostatic carcinoma who after routine staging have no evidence of distant metastasis. Patients will be male and over 40 years of age. In general external beam treatment is delivered as an outpatient whilst the interstitial treatment will require two to three days inpatient care.

Exclusion Criteria

  • •1\. Prostate specific antigen (PSA) over 50
  • •2\. Previous Transurethral Resection of the Prostate (TURP)
  • •3\. Radiological evidence of distant metastasis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
SABRE 1: Surgery Against Brachytherapy - a Randomised EvaluatioProstate cancerCancerMalignant neoplasm of prostate
ISRCTN88144169Southampton University Hospitals NHS Trust (UK)400
Recruiting
Phase 1
Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney CancerStage I Renal Cell CancerStage II Renal Cell Cancer
NCT04473781Jonsson Comprehensive Cancer Center17
Completed
Not Applicable
Intraluminal brachytherapy treatment results analysis of unresectable recurrent cholangiocarcinomaNeoplasms
KCT0000738Chonbuk National University Hospital30
Completed
Early Phase 1
Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck CancerHead and Neck CancerHead and Neck Squamous Cell Carcinoma
NCT02794675Case Comprehensive Cancer Center15
Terminated
Phase 2
Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative ColitisUlcerative ColitisIBD
NCT03616821AstraZeneca242